Assure Tech (Hangzhou) Co., Ltd. (SHA:688075)

China · Delayed Price · Currency is CNY

28.32

+0.24 (0.85%)

Aug 4, 2026, 3:00 PM CST

-31.92% (1Y)

Market Cap	3.57B -32.5%
Revenue (ttm)	407.16M -22.7%
Net Income	25.03M -84.0%
EPS	0.20 -84.0%
Shares Out	127.08M
PE Ratio	142.56
Forward PE	n/a
Dividend	0.80 (2.85%)
Ex-Dividend Date	Jul 9, 2026

Volume	1,024,283
Open	28.13
Previous Close	28.08
Day's Range	28.02 - 28.37
52-Week Range	26.88 - 45.00
Beta	0.58
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About Assure Tech (Hangzhou)

Assure Tech (Hangzhou) Co., Ltd. engages in the research and development, production, and sale of vitro diagnostic reagents, and instruments in China and internationally. The company is involved in POCT and plastic product manufacturing; online sales; pharmaceutical manufacturing and sales; and medical testing. It also offers drug of abuse, infectious disease, fertility, cardiac marker, tumor marker, allergen, and veterinary tests, as well as Biochemistry, chronic disease monitoring systems, and reader and analyzers. In addition, the company of... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2008

Employees 551

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688075

Full Company Profile

Financial Performance

In 2025, Assure Tech (Hangzhou)'s revenue was 451.26 million, a decrease of -16.54% compared to the previous year's 540.70 million. Earnings were 69.42 million, a decrease of -63.90%.

Financial Statements